RTM
BCAX

Red Tree Management’s Bicara Therapeutics BCAX Stock Holding History

Red Tree Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.9M Sell
3,163,517
-6,992
-0.2% -$156K 63.77% 1
2026
Q1 		$63.1M Hold
3,170,509
– – 56.39% 1
2025
Q4 		$53.4M Hold
3,170,509
– – 48.94% 1
2025
Q3 		$50.1M Hold
3,170,509
– – 60.39% 1
2025
Q2 		$29.5M Hold
3,170,509
– – 40.18% 2
2025
Q1 		$41.3M Hold
3,170,509
– – 44.61% 2
2024
Q4 		$55.2M Buy
+3,170,509
New +$66M 36.35% 2

Other funds holding BCAX

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
NG
Norden Group Provo, Utah $1.22B AUM 36.64% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Red Tree Management's BCAX Position: Q2 2026 in Review

Red Tree Management reduced its Bicara Therapeutics (BCAX) stake by 0.22% in Q2 2026, selling an estimated $156K and leaving 3,163,517 shares worth $93.9M. The position accounts for 63.77% of the portfolio, ranked #1.

Red Tree Management first reported a position in BCAX in Q4 2024 and has held it in 7 quarters since. 20 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Red Tree Management held 3,163,517 shares of Bicara Therapeutics worth $93.9M as of Q2 2026.
  • Red Tree Management sold 6,992 Bicara Therapeutics shares in Q2 2026, an estimated $156K.
  • Bicara Therapeutics made up 63.77% of Red Tree Management's portfolio in Q2 2026, its #1 holding.
  • Red Tree Management first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 20 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Red Tree Management's 13F filing for Q2 2026, filed 22 Jul 2026.